Celldex Therapeutics, Inc. Announces Upcoming Presentation at the Leerink Swann and Company Rare Disease Roundtable
Published: Sep 26, 2013
PHILLIPSBURG, N.J., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that Anthony Marucci, President and Chief Executive Officer, and Tibor Keler, PhD, Senior Vice President and Chief Scientific Officer, will present at the Leerink Swann Rare Disease Roundtable on Wednesday, October 2, 2013 at 3:20 p.m. ET at the Le Parker Meridien in New York City.
Help employers find you! Check out all the jobs and post your resume.